Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer

1 Apr 2007

Abstract excerpt

PURPOSE: New methods to accurately predict an individual tumor behavior are urgently required to improve the treatment of cancer. We previously found that promoter hypermethylation can be an accurate predictor of bladder cancer progression, but it is not cancer specific. Here, we investigate a panel of methylated loci in a prospectively collected cohort of bladder tumors to determine whether hypermethylation has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17404085
DOI: 10.1158/1078-0432.ccr-06-2476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter Hypermethylation Identifies Progression Risk in Bladder CancerPMID 17404085Read ↗

Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder CancerSemantic proximity Read ↗

Alterations of DNA methylome in human bladder cancerSemantic proximity Read ↗

A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancerSemantic proximity Read ↗

DNA Hypermethylation of a panel of genes as an urinary biomarker for bladder cancer diagnosisSemantic proximity Read ↗

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder CancerSemantic proximity Read ↗

Promoter Hypermethylation Is Associated With Tumor Location, Stage, and Subsequent Progression in Transitional Cell CarcinomaSemantic proximity Read ↗

The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine SedimentsSemantic proximity Read ↗

A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder CancerSemantic proximity Read ↗

Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancerSemantic proximity Read ↗

Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genesSemantic proximity Read ↗

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.